Dexmedetomidine and Adenosine: Therapeutic Use for SVT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01495481|
Recruitment Status : Completed
First Posted : December 20, 2011
Results First Posted : March 28, 2017
Last Update Posted : March 28, 2017
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
All 22 patients recruited received both adenosine and dexmedetomidine. Adenosine was administered first ,and then SVT was reinduced. Once SVT was reinduced, dexmedetomidine was administered.
The washout period was not constant because it was dependent upon the reinduction of SVT, but it was generally less than 10 min.